)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Initiator Pharma
Initiator Pharma (INIT) investor relations material
Initiator Pharma Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary20 Feb, 2026
Executive summary
Transitioned from clinical preparation to execution with the start of a Phase IIa trial for pudafensine in vulvodynia after UK regulatory approval in November 2025.
First patients dosed in the vulvodynia study, marking a key milestone and entry into a new therapeutic area.
Strengthened IP position with a European patent granted for pudafensine in Female Sexual Dysfunction in February 2026.
Business development activities intensified, including presence at the J.P. Morgan Healthcare Conference and ongoing partnering discussions.
Financial highlights
No revenue generated in Q4 or FY 2025.
Q4 2025 operating loss of TDKK 6,966, up from TDKK 2,701 in Q4 2024, reflecting increased R&D costs.
Net loss after tax for Q4 2025 was TDKK 2,920 (Q4 2024: TDKK 851); FY 2025 net loss was TDKK 13,687 (FY 2024: TDKK 12,932).
Cash and cash equivalents at year-end 2025 were TDKK 26,245, up from TDKK 13,371 at year-end 2024.
Equity increased to TDKK 29,546 at December 31, 2025 (2024: TDKK 14,782).
Outlook and guidance
Patient recruitment ongoing for the Phase IIa vulvodynia study, with topline results expected in late 2026.
Company expects to be financed well into 2027 following the rights issue and convertible credit agreement.
How does MAC's convertible credit impact financing?
Next steps for FSD program development
What milestones trigger next capital raise?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Initiator Pharma earnings date
Q1 20268 May, 2026
Initiator Pharma
Next Initiator Pharma earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Initiator Pharma A/S is a Danish clinical-stage biopharmaceutical company focusing on developing treatments for unmet medical needs related to the central and peripheral nervous systems. The company’s portfolio primarily targets disorders such as erectile dysfunction (ED) and neuropathic pain. Its clinical programs include drug candidates for both psychogenic and organic ED as well as a rare disease program for Trigeminal Neuralgia, a chronic pain condition. Initiator Pharma leverages its expertise in monoamine reuptake inhibitors, which increase key neurotransmitters like dopamine to treat various neurological conditions. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage